Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-08 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |